Orion Infusion Statistics

Total Valuation

Orion Infusion has a market cap or net worth of BDT 6.19 billion. The enterprise value is 6.46 billion.

Market Cap	6.19B
Enterprise Value	6.46B

Important Dates

The last earnings date was Monday, November 4, 2024.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Infusion has 20.36 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	20.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	18.85%
Owned by Institutions (%)	n/a
Float	12.09M

Valuation Ratios

The trailing PE ratio is 144.98.

PE Ratio	144.98
Forward PE	n/a
PS Ratio	7.28
PB Ratio	20.39
P/TBV Ratio	n/a
P/FCF Ratio	159.16
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.34, with an EV/FCF ratio of 166.18.

EV / Earnings	151.38
EV / Sales	7.60
EV / EBITDA	62.34
EV / EBIT	78.21
EV / FCF	166.18

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.98.

Current Ratio	0.86
Quick Ratio	0.26
Debt / Equity	0.98
Debt / EBITDA	2.87
Debt / FCF	7.66
Interest Coverage	2.70

Financial Efficiency

Return on equity (ROE) is 14.62% and return on invested capital (ROIC) is 8.52%.

Return on Equity (ROE)	14.62%
Return on Assets (ROA)	6.57%
Return on Capital (ROIC)	8.52%
Revenue Per Employee	1.11M
Profits Per Employee	55,896
Employee Count	764
Asset Turnover	1.08
Inventory Turnover	3.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.59%
50-Day Moving Average	315.39
200-Day Moving Average	481.91
Relative Strength Index (RSI)	49.97
Average Volume (20 Days)	195,769

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Infusion had revenue of BDT 850.39 million and earned 42.70 million in profits. Earnings per share was 2.10.

Revenue	850.39M
Gross Profit	341.87M
Operating Income	82.66M
Pretax Income	51.26M
Net Income	42.70M
EBITDA	95.08M
EBIT	82.66M
Earnings Per Share (EPS)	2.10

Full Income Statement

Balance Sheet

The company has 19.24 million in cash and 298.12 million in debt, giving a net cash position of -272.99 million or -13.41 per share.

Cash & Cash Equivalents	19.24M
Total Debt	298.12M
Net Cash	-272.99M
Net Cash Per Share	-13.41
Equity (Book Value)	303.72M
Book Value Per Share	14.92
Working Capital	-64.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 113.36 million and capital expenditures -74.46 million, giving a free cash flow of 38.90 million.

Operating Cash Flow	113.36M
Capital Expenditures	-74.46M
Free Cash Flow	38.90M
FCF Per Share	1.91

Full Cash Flow Statement

Margins

Gross margin is 40.20%, with operating and profit margins of 9.72% and 5.02%.

Gross Margin	40.20%
Operating Margin	9.72%
Pretax Margin	6.03%
Profit Margin	5.02%
EBITDA Margin	11.18%
EBIT Margin	9.72%
FCF Margin	4.57%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.33%.

Dividend Per Share	1.00
Dividend Yield	0.33%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	26.04%
Buyback Yield	n/a
Shareholder Yield	0.33%
Earnings Yield	0.69%
FCF Yield	0.63%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Orion Infusion has an Altman Z-Score of 10.96.

Altman Z-Score	10.96
Piotroski F-Score	n/a